Chicago Social Drinking Project
Brief Summary
Skip to Participation Criteria
Official Title: "Individual Differences After Consumption of Alcohol and Other Common Substances and Long-Term Follow-Up of Social Drinking, Young Adults"
This study attempts to elucidate the factors that contribute to escalation and maintenance of excessive ethanol drinking in young adults by:
1. Examining subjective and objective response differences to alcohol and other common substances in a sample of young, adult social drinkers with varying consumption patterns.
2. Determining whether response to alcohol and other substances is predictive of future consumption patterns through longitudinal follow-up interviews.
3. Examining the relationship between responses to alcohol and other substances at baseline and re-examination testing to evaluate if consumption patterns moderate this relationship.
- Study Type: Interventional
- Study Design: Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Screening
- Study Primary Completion Date: July 2016
Interventions Used in this Clinical Trial
- Drug: Ethanol
- Beverage containing 0.8 g/kg ethanol, 0.4 g/kg ethanol
- Drug: Placebo
- Beverage containing 0.0 g/kg alcohol to act as placebo
- Drug: Diphenhydramine
- Beverage containing dose equivalent to 1.5 standard doses of Diphenhydramine (Benadryl)
- Drug: Caffeine
- Beverage containing the equivalent of 1.5 times the participant's daily caffeine intake
Arms, Groups and Cohorts in this Clinical Trial
- Experimental: Beverage with Heavy Alcohol Dose
- Beverage containing 0.8 g/kg alcohol
- Experimental: Beverage with Low Alcohol Dose
- Beverage containing 0.4 g/kg alcohol
- Placebo Comparator: Beverage with No alcohol (Placebo)
- Beverage containing 0.0 g/kg alcohol to act as placebo
- Experimental: Beverage with Diphenhydramine
- Beverage containing 1.5 standard dose of Diphenhydramine (Benadryl)
- Experimental: Beverage with Caffeine
- Beverage containing the equivalent of 1.5 times participant's average caffeine consumption
Outcome Measures for this Clinical Trial
Primary Measures
- Subjective response to alcohol and other common substances utilizing mood questionnaires in social drinking young adults
- Time Frame: Measured during 5 timepoints at each experimental session: 1) Pre-drink baseline, 2) +30 minutes, 3) +60 minutes, 4) +120 minutes, and 5) +180 minutes following the initiation of beverage consumption
Safety Issue?: No
- Time Frame: Measured during 5 timepoints at each experimental session: 1) Pre-drink baseline, 2) +30 minutes, 3) +60 minutes, 4) +120 minutes, and 5) +180 minutes following the initiation of beverage consumption
Secondary Measures
- Substance Use Behavior Reported During Follow-Up Interviews
- Time Frame: Measured at 3, 6, 9, 12, 15, 18, 21, 24, 36, 48, and 60 months following the final experimental session
Safety Issue?: No
- Time Frame: Measured at 3, 6, 9, 12, 15, 18, 21, 24, 36, 48, and 60 months following the final experimental session
Criteria for Participation in this Clinical Trial
Inclusion Criteria
- Age 21-29
- Weigh between 110-210 lbs
- Drink alcohol at least once weekly with weekly "binge" drinking episodes
- Available to complete in-person screening and 2, 4 hour experimental sessions at the University of Chicago
- Available by phone, mail, or Internet for follow-up interviews for at least 2 years following sessions
Exclusion Criteria
- Current or past major medical or psychiatric disorders including alcohol and substance dependence
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 21 Years
Maximum Age for this Clinical Trial: 29 Years
Are Healthy Volunteers Accepted for this Clinical Trial: No
Clinical Trial Investigator Information
- Lead Sponsor
- University of Chicago
- Collaborator
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- Provider of Information About this Clinical Study
- Principal Investigator: Andrea King, Ph.D - University of Chicago
- Overall Official(s)
- Andrea C King, PhD, Principal Investigator, University of Chicago
References
King AC, Byars JA. Alcohol-induced performance impairment in heavy episodic and light social drinkers. J Stud Alcohol. 2004 Jan;65(1):27-36.
King AC, Houle T, de Wit H, Holdstock L, Schuster A. Biphasic alcohol response differs in heavy versus light drinkers. Alcohol Clin Exp Res. 2002 Jun;26(6):827-35.
Citations Reporting on Results
Rueger SY, McNamara PJ, King AC. Expanding the utility of the Biphasic Alcohol Effects Scale (BAES) and initial psychometric support for the Brief-BAES (B-BAES). Alcohol Clin Exp Res. 2009 May;33(5):916-24. Epub 2009 Mar 11.
Epstein AM, Sher TG, Young MA, King AC. Tobacco chippers show robust increases in smoking urge after alcohol consumption. Psychopharmacology (Berl). 2007 Feb;190(3):321-9. Epub 2006 Jun 28.
Brumback T, Cao D, King A. Effects of alcohol on psychomotor performance and perceived impairment in heavy binge social drinkers. Drug Alcohol Depend. 2007 Nov 2;91(1):10-7. Epub 2007 Jun 8.
King A, Epstein A, Conrad M, McNamara P, Cao D. Sex differences in the relationship between alcohol-associated smoking urge and behavior: a pilot study. Am J Addict. 2008 Sep-Oct;17(5):347-53.
King AC, Epstein AM. Alcohol dose-dependent increases in smoking urge in light smokers. Alcohol Clin Exp Res. 2005 Apr;29(4):547-52.
Additional Information on this Clinical Trial
Information obtained from ClinicalTrials.gov on May 16, 2013
Link to the current ClinicalTrials.gov record. - http://clinicaltrials.gov/show/NCT00961792
Study ID Number: 12119a
ClinicalTrials.gov Identifier: NCT00961792
Health Authority: United States: Institutional Review Board